Sequential treatment with secukinumab and ustekinumab in a patient with severe psoriasis and recent history of cerebral malignant melanoma metastasis

Misbah N. Ghazanfar; Tonny Karlsmark; Patricia Louise Danielsen; Simon F. Thomsen

doi:10.1002/ccr3.2225

Sequential treatment with secukinumab and ustekinumab in a patient with severe psoriasis and recent history of cerebral malignant melanoma metastasis

Misbah N. Ghazanfar, Tonny Karlsmark, Patricia Louise Danielsen, Simon F. Thomsen

2 Citationer (Scopus)

14 Downloads (Pure)

Abstract

This report of a 53-year-old woman with severe psoriasis treated with biologic therapy despite recent history of malignant melanoma with cerebral metastasis suggests that biologic therapy for chronic inflammatory diseases may be an option for selected patients with recent cancer.

Originalsprog	Engelsk
Tidsskrift	Clinical Case Reports
Vol/bind	7
Udgave nummer	7
Sider (fra-til)	1350-1351
ISSN	2050-0904
DOI	https://doi.org/10.1002/ccr3.2225
Status	Udgivet - jul. 2019

FN’s Verdensmål

Dette resultat bidrager til følgende verdensmål

Adgang til dokumentet

10.1002/ccr3.2225

Ghazanfar_et_al-2019-Clinical_Case_ReportsForlagets udgivne version, 75,3 KBLicens: Ikke-specificeret

Citationsformater

Sequential treatment with secukinumab and ustekinumab in a patient with severe psoriasis and recent history of cerebral malignant melanoma metastasis. / Ghazanfar, Misbah N.; Karlsmark, Tonny; Danielsen, Patricia Louise et al.
I: Clinical Case Reports, Bind 7, Nr. 7, 07.2019, s. 1350-1351.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

@article{eadeab8415684343ba8bbf6b057a9d11,

title = "Sequential treatment with secukinumab and ustekinumab in a patient with severe psoriasis and recent history of cerebral malignant melanoma metastasis",

abstract = "This report of a 53-year-old woman with severe psoriasis treated with biologic therapy despite recent history of malignant melanoma with cerebral metastasis suggests that biologic therapy for chronic inflammatory diseases may be an option for selected patients with recent cancer.",

keywords = "cancer, malignant melanoma, psoriasis, secukinumab, ustekinumab",

author = "Ghazanfar, {Misbah N.} and Tonny Karlsmark and Danielsen, {Patricia Louise} and Thomsen, {Simon F.}",

year = "2019",

month = jul,

doi = "10.1002/ccr3.2225",

language = "English",

volume = "7",

pages = "1350--1351",

journal = "Clinical Case Reports",

issn = "2050-0904",

publisher = "JohnWiley & Sons Ltd",

number = "7",

}

TY - JOUR

T1 - Sequential treatment with secukinumab and ustekinumab in a patient with severe psoriasis and recent history of cerebral malignant melanoma metastasis

AU - Ghazanfar, Misbah N.

AU - Karlsmark, Tonny

AU - Danielsen, Patricia Louise

AU - Thomsen, Simon F.

PY - 2019/7

Y1 - 2019/7

N2 - This report of a 53-year-old woman with severe psoriasis treated with biologic therapy despite recent history of malignant melanoma with cerebral metastasis suggests that biologic therapy for chronic inflammatory diseases may be an option for selected patients with recent cancer.

AB - This report of a 53-year-old woman with severe psoriasis treated with biologic therapy despite recent history of malignant melanoma with cerebral metastasis suggests that biologic therapy for chronic inflammatory diseases may be an option for selected patients with recent cancer.

KW - cancer

KW - malignant melanoma

KW - psoriasis

KW - secukinumab

KW - ustekinumab

U2 - 10.1002/ccr3.2225

DO - 10.1002/ccr3.2225

M3 - Journal article

C2 - 31360484

SN - 2050-0904

VL - 7

SP - 1350

EP - 1351

JO - Clinical Case Reports

JF - Clinical Case Reports

IS - 7

ER -